AbbVie Inc (ABBV)
166.41
+1.75
(+1.06%)
USD |
NYSE |
Apr 19, 16:00
166.51
+0.10
(+0.06%)
After-Hours: 17:25
AbbVie Profit Margin (Quarterly): 5.75% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.75% |
| September 30, 2023 | 12.77% |
| June 30, 2023 | 14.60% |
| March 31, 2023 | 1.96% |
| December 31, 2022 | 16.35% |
| September 30, 2022 | 26.66% |
| June 30, 2022 | 6.34% |
| March 31, 2022 | 33.17% |
| December 31, 2021 | 27.17% |
| September 30, 2021 | 22.17% |
| June 30, 2021 | 5.49% |
| March 31, 2021 | 27.31% |
| December 31, 2020 | 0.26% |
| September 30, 2020 | 17.89% |
| June 30, 2020 | -7.08% |
| March 31, 2020 | 34.92% |
| December 31, 2019 | 32.18% |
| September 30, 2019 | 22.22% |
| June 30, 2019 | 8.98% |
| March 31, 2019 | 31.37% |
| December 31, 2018 | -21.99% |
| September 30, 2018 | 33.35% |
| June 30, 2018 | 23.96% |
| March 31, 2018 | 35.08% |
| December 31, 2017 | 0.67% |
| Date | Value |
|---|---|
| September 30, 2017 | 23.32% |
| June 30, 2017 | 27.58% |
| March 31, 2017 | 26.17% |
| December 31, 2016 | 20.47% |
| September 30, 2016 | 24.84% |
| June 30, 2016 | 24.95% |
| March 31, 2016 | 22.73% |
| December 31, 2015 | 23.70% |
| September 30, 2015 | 20.84% |
| June 30, 2015 | 24.95% |
| March 31, 2015 | 20.28% |
| December 31, 2014 | -14.86% |
| September 30, 2014 | 10.08% |
| June 30, 2014 | 22.29% |
| March 31, 2014 | 21.48% |
| December 31, 2013 | 22.07% |
| September 30, 2013 | 20.70% |
| June 30, 2013 | 22.76% |
| March 31, 2013 | 22.36% |
| December 31, 2012 | 29.58% |
| September 30, 2012 | 35.16% |
| June 30, 2012 | 28.20% |
| March 31, 2012 | 21.16% |
| December 31, 2011 | 23.80% |
| September 30, 2011 | 0.28% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.08%
Minimum
Jun 2020
34.92%
Maximum
Mar 2020
16.27%
Average
16.35%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 9.36% |
| Gilead Sciences Inc | 20.09% |
| Immunogen Inc (DELISTED) | 27.11% |
| Johnson & Johnson | 25.04% |
| Eli Lilly and Co | 23.41% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.83% |
| Return on Assets | 3.58% |
| Return on Invested Capital | 6.53% |
| Gross Profit Margin (Quarterly) | 60.11% |
| Operating Margin (Quarterly) | 24.31% |
| Return on Net Operating Assets | 4.26% |